unknown
Stage
1
Investors
About
clock.bio develops a platform that identifies and validates genetic programs enabling cellular rejuvenation, focusing initially on skin rejuvenation topicals and nutraceuticals to extend human healthspan.
Explore clock.bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.